Correlation between benign prostatic hyperplasia and comorbidities: a systematic analysis integrating global burden

Zhenfeng Song1, Zhangkai J Cheng2, Hong Yuan3

  • 1The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

PubMed

Insights

Benign prostatic hyperplasia (BPH) is linked to prostatitis and prostate cancer. This study used genetic methods to confirm these causal relationships, offering new insights into BPH comorbidities.

Area of Science:

  • Urology
  • Genetics
  • Epidemiology

Background:

  • Benign prostatic hyperplasia (BPH) is a prevalent condition in aging men with numerous identified comorbidities.
  • Previous observational studies are limited by confounding factors, hindering clear causal explanations for BPH-comorbidity associations.
  • This research leverages the Global Burden of Disease (GBD) database and Mendelian randomization (MR) to investigate BPH-comorbidity links.

Purpose of the Study:

  • To investigate the association between benign prostatic hyperplasia (BPH) and its comorbidities.
  • To elucidate potential causal relationships between BPH and specific comorbidities using advanced genetic and epidemiological methods.
  • To explore socio-economic, environmental, and genetic factors influencing BPH and its associated conditions.

Main Methods:

  • Utilized Global Burden of Disease (GBD) data for correlation analysis of 9 significant comorbidities with BPH.
  • Employed Linkage Disequilibrium Score Regression (LDSC) to identify genetic connections between BPH and 20 comorbidities.
  • Conducted univariable and multivariable bidirectional Mendelian randomization (MR) analyses, supplemented by Steiger directionality tests for causal inference.

Main Results:

  • Correlation analysis revealed associations between BPH and prostate cancer, chronic kidney disease, and depression.
  • LDSC identified links between BPH and prostatitis and bladder cancer.
  • Bidirectional MR confirmed causal links between BPH and increased risk of prostatitis and prostate cancer, supported by sensitivity analyses and colocalization of shared genetic loci.

Conclusions:

  • Established causal relationships between benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer.
  • Identified potential mediating factors, such as diet and chronotype, influencing the risk of prostatitis and prostate cancer in relation to BPH.
  • Provides a novel perspective on understanding the complex comorbid associations of BPH.
Abstract